申请人:Seattle Genetics, Inc.
公开号:EP3513794A2
公开(公告)日:2019-07-24
The invention provides compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
本发明提供了通过服用岩藻
糖类似物抑制体内蛋白质(包括
抗体)岩藻糖基化的组合物。